Western blotting and ELISA also validated the upregulation of C5a and IL‐1β in FGF19‐conditioned LX‐2 cells (Figure 5C,D; Figure S6A, Supporting Information), but not in CRC cells (Figure S6B, Supporting Information). The gene discussed is FGF19; the disease is colorectal carcinoma.